Biontech Se Adr (BNTX)

Nov 16, 2024

BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register

Nov 16, 2024

Nov 15, 2024

Powell Speaks The Truth - Benzinga

Nov 15, 2024

Nov 15, 2024

Goodwin, Conyers, A&O Shearman Act on $800M China Biotech Sale - Law.com International

Nov 15, 2024

Nov 14, 2024

BioNTech ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Nov 14, 2024

Nov 13, 2024

BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch

Nov 13, 2024

Nov 13, 2024

BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition - Benzinga

Nov 13, 2024

Nov 12, 2024

BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch

Nov 12, 2024

Nov 11, 2024

BioNTech SE ADR falls Monday, underperforms market - MarketWatch

Nov 11, 2024

Nov 08, 2024

BioNTech SE ADR rises Friday, outperforms market - MarketWatch

Nov 08, 2024

Nov 06, 2024

BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch

Nov 06, 2024

Nov 05, 2024

BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch

Nov 05, 2024

Nov 04, 2024

BioNTech SE Reports Strong Q3 2024 Results - TipRanks

Nov 04, 2024

Nov 04, 2024

This 6%-yielding U.S. pharma giant is a safe hold - The Globe and Mail

Nov 04, 2024

Nov 01, 2024

BioNTech SE ADR falls Friday, underperforms market - MarketWatch

Nov 01, 2024

Oct 31, 2024

BioNTech SE ADR outperforms market despite losses on the day - MarketWatch

Oct 31, 2024

Oct 28, 2024

Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? - Nasdaq

Oct 28, 2024

Oct 28, 2024

BioNTech to Report Q3 Earnings: Is a Beat in the Cards? - MSN

Oct 28, 2024

Oct 24, 2024

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

Oct 24, 2024

Oct 21, 2024

BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat - Morningstar

Oct 21, 2024

Oct 16, 2024

BioNTech SE ADR rises Wednesday, still underperforms market - MarketWatch

Oct 16, 2024

Oct 15, 2024

A better buy-in window may exist right now for BioNTech SE ADR (BNTX) - SETE News

Oct 15, 2024

Oct 09, 2024

Insider’s View: Deciphering BioNTech SE ADR (BNTX)’s Financial Health Through Ratios - The Dwinnex

Oct 09, 2024

Oct 08, 2024

BioNTech SE ADR (BNTX)’s stock decline to 121.55 per share - US Post News

Oct 08, 2024

Oct 07, 2024

BioNTech SE ADR falls Monday, still outperforms market - MarketWatch

Oct 07, 2024

Oct 07, 2024

What is BioNTech SE ADR (BNTX) Stock Return on Shareholders’ Capital? - SETE News

Oct 07, 2024

Oct 03, 2024

BioNTech SE ADR (BNTX)’s results reveal risk - US Post News

Oct 03, 2024

Oct 02, 2024

Gaining Ground: BioNTech SE ADR (BNTX) Closes Higher at 119.93, Up 0.98 - The Dwinnex

Oct 02, 2024

Oct 01, 2024

ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty - Yahoo Finance

Oct 01, 2024

Oct 01, 2024

BioNTech unveils AI advancements in immunotherapy - Investing.com

Oct 01, 2024

Sep 30, 2024

BioNTech SE ADR rises Monday, outperforms market - MarketWatch

Sep 30, 2024

Sep 30, 2024

BioNTech SE ADR (BNTX) can make a big difference with a little luck - SETE News

Sep 30, 2024

Sep 27, 2024

Wall Street SWOT: BioNTech stock shows promise amid oncology pipeline growth - Investing.com

Sep 27, 2024

Sep 26, 2024

Are Smart Investors Making the Right Decision? BioNTech SE ADR (BNTX) - SETE News

Sep 26, 2024

Sep 24, 2024

What Are You Thinking About Investing In BioNTech SE ADR (NASDAQ: BNTX) Stock? - Stocks Register

Sep 24, 2024